Study of surgeons’ experiences and how to assess new ideas
Part of Cancer clinical trials.
This study looks at surgeons who treat cancer in France and gathers information about their experiences and views. The goal is to improve how new cancer-related innovations are evaluated, which may lead to better decision-making in future care.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are a surgeon who treats cancer (oncology) in France
- You can be contacted by email through a participating organization or group
- No other exclusion rules were listed for this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study gathers information from urology patients using digital tools like email or apps. Your feedback could help improve care for others with urology conditions.
This study is tracking patients who receive new types of endoscopy procedures at specialized centers. It aims to gather information on how these newer techniques work in real-world practice.
This study collects medical information and small tissue or fluid samples from people with peritoneal (abdominal lining) cancer. It aims to better understand the disease and improve future care plans.
This trial builds a national database of people diagnosed with sarcoma in French cancer centers. It may help researchers better understand sarcoma types and care patterns, which can improve future treatment decisions.
This trial evaluates surgeons' awareness through training and testing. It may help improve surgical practices and patient safety.
This trial looks at how people understand health information and what they expect before and after major cancer surgery. The goal is to help doctors better support patients by learning about their hopes and possible regrets.
Hear when a new Surgery trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.